Change search
ReferencesLink to record
Permanent link

Direct link
Radical generation and stabilisation in ribonucleotide reductase R2
Stockholm University, Faculty of Science, Department of Biochemistry and Biophysics.
2003 (English)Doctoral thesis, monograph (Other academic)
Abstract [en]

Diiron carboxylate proteins contain a cofactor that consists of two iron atoms coordinated by carboxylate and histidine ligands. These proteins perform a multitude of chemical reactions in the cell that generally involve activation of molecular oxygen at the diiron site.

Ribonucleotide reductase is the only enzyme that performs de novo synthesis of all four deoxyribonucleotides, the building blocks of DNA. The R2 protein of Class-I ribonucleotide reductase, which is a diiron carboxylate protein, utilises the high-valent iron-oxygen species generated at the diiron site to produce a stable tyrosyl radical required for enzymatic activity.

In this work, X-ray crystallography and EPR are used to study the R2 protein from Escherichia coli with the goal of understanding its mechanism of oxygen activation, radical generation and radical stabilisation. Based on these studies a detailed structural mechanism is proposed, which might be common to several oxygen activating diiron carboxylate proteins. The orientation of the active radical species in R2 has also been determined. In addition, these results provide a rationale for the unusual stability of the radical.

Crystal structures of R2 proteins from two other species, Corynebacterium ammoniagenes and Chlamydia trachomatis, have also been solved.

The C. ammoniagenes protein has been reported to be manganese-dependent. The results presented here, however, support dependence of iron and not manganese.

Sequence alignments indicate that the chlamydial R2s lack the, otherwise conserved, radical harbouring tyrosine. This is confirmed by the structure, which also reveals other unique features in the diiron site. Hypotheses regarding the function of the protein and the reason for the differences are presented.

Place, publisher, year, edition, pages
2003. , 77 p.
National Category
Medical Biotechnology (with a focus on Cell Biology (including Stem Cell Biology), Molecular Biology, Microbiology, Biochemistry or Biopharmacy)
Research subject
URN: urn:nbn:se:su:diva-19926ISBN: 91-7265-711-1OAI: diva2:186450
Public defence
2003-11-21, Magnélisalen, KÖL, Frescati, 10:00 (English)
Available from: 2007-11-20 Created: 2007-11-20 Last updated: 2009-12-16Bibliographically approved

Open Access in DiVA

No full text

Search in DiVA

By author/editor
Högbom, Martin
By organisation
Department of Biochemistry and Biophysics
Medical Biotechnology (with a focus on Cell Biology (including Stem Cell Biology), Molecular Biology, Microbiology, Biochemistry or Biopharmacy)

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Total: 68 hits
ReferencesLink to record
Permanent link

Direct link